PUBLISHER: MarketLine | PRODUCT CODE: 1125538
PUBLISHER: MarketLine | PRODUCT CODE: 1125538
The BRIC Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Brazil, Russian Federation, India and China (BRIC) are the emerging and fast growing countries within the generics industry and had a total market value of $114,747.5 million in 2021. Russia was the fastest growing country with a CAGR of 10.7% over the 2017-21 period.
Within the generics industry, China is the leading country among the BRIC nations with market revenues of $85,327.0 million in 2021. This was followed by India, Russia and Brazil with a value of $17,283.5, $9,801.3, and $2,335.6 million, respectively.
China is expected to lead the generics industry in the BRIC nations with a value of $102,263.8 million in 2026, followed by India, Russia, Brazil with expected values of $26,692.2, $14,529.5 and $3,309.4 million, respectively.